[Favorable response to cyclosporin A in a patient with steroid resistant autoimmune haemolytic anaemia]
- PMID: 15074296
[Favorable response to cyclosporin A in a patient with steroid resistant autoimmune haemolytic anaemia]
Abstract
We present a patient with isolated steroid resistant autoimmune haemolytic anaemia successfully treated with cyclosporin A for 7 months with no adverse side effects and free of disease after 2 years of therapy. We thus recommend to consider cyclosporin A as a first choice in steroid resistant patients with autoimmune haemolytic anaemia. More studies are necessary to assess the efficacy and safety of this treatment.
Similar articles
-
Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.Br J Haematol. 2009 Apr;145(1):96-100. doi: 10.1111/j.1365-2141.2009.07594.x. Epub 2009 Feb 4. Br J Haematol. 2009. PMID: 19208098
-
Successful management of severe chronic autoimmune hemolytic anemia with low dose cyclosporine and prednisone in an infant.Turk J Pediatr. 2003 Oct-Dec;45(4):335-7. Turk J Pediatr. 2003. PMID: 14768800
-
Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options.Dig Liver Dis. 2006 Nov;38(11):846-50. doi: 10.1016/j.dld.2005.09.013. Epub 2005 Nov 2. Dig Liver Dis. 2006. PMID: 16266839
-
Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.Am J Gastroenterol. 1999 Jan;94(1):241-8. doi: 10.1111/j.1572-0241.1999.00807.x. Am J Gastroenterol. 1999. PMID: 9934764 Review.
-
Autoimmune haemolytic anaemia in a newborn infant.Arch Dis Child Fetal Neonatal Ed. 2003 Jul;88(4):F341-2. doi: 10.1136/fn.88.4.f341. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 12819171 Free PMC article. Review.
Cited by
-
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers.Ther Adv Hematol. 2022 May 14;13:20406207221097780. doi: 10.1177/20406207221097780. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35585968 Free PMC article.